CompletedNCT04186403
Official study titleA Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Adult Subjects With Borderline Personality Disorder
This study has finished and is no longer accepting participants.
In New YorkPersonality disordersMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT01635556
Official study titleEvaluation of a Modified Dialectical Behavior Therapy Program for Borderline Personality Disorder
This study has finished and is no longer accepting participants.
In WinnipegPersonality disordersObservational studyAges 18–65
- Countries
- Canada
- Sponsor
- University of Manitoba
UnknownNCT01683136
Official study titleEvaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Feasibility Study for the Treatment of Borderline Personality Disorder
Current recruitment status is unconfirmed.
In Hod HaSharonPersonality disordersDevice studyAges 18–60
- Countries
- Israel
- Sponsor
- Shalvata Mental Health Center
UnknownNCT05710926
Official study titleA Confirmatory Randomized Controlled Trial Comparing Evolutionary Systems Therapy for Schizotypal Personality Disorder With Cognitive Behavioral Therapy
Current recruitment status is unconfirmed.
In FlorencePersonality disordersBehavioural studyAges 18+
- Countries
- Italy
- Sponsor
- Tages Onlus
CompletedNCT04587518
What is this study about?This study assessed anxiety symptoms.
This study has finished and is no longer accepting participants.
In LexingtonPersonality disordersBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- Shannon E. Sauer-Zavala
UnknownNCT00358969
Official study titleGuanfacine in the Treatment of Borderline Personality Disorder
Current recruitment status is unconfirmed.
In New YorkPersonality disordersMedication studyAges 18–55
- Countries
- United States
- Sponsor
- Icahn School of Medicine at Mount Sinai
CompletedNCT00154154
Official study titleHope for the Chronically Suicidal Patient: Evaluating the Clinical and Health Services Impact of Dialectical Behaviour Therapy in Individuals With Borderline Personality Disorder
This study has finished and is no longer accepting participants.
In TorontoPersonality disordersBehavioural studyAges 18–60
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health (Hospital / academic medical center)
CompletedNCT06076343
Official study titleAn Integrated Approach to Treatment of People With Borderline Personality Disorder and Their Caregivers
This study has finished and is no longer accepting participants.
In BresciaPersonality disordersBehavioural studyAges 18–50
- Countries
- Italy
- Sponsor
- IRCCS Centro San Giovanni di Dio Fatebenefratelli
CompletedNCT05383300
Official study titleInvestigating the Effect of Oxytocin and the Neurochemistry of Antisocial Personality Disorder and Psychopathy Using Neuroimaging
This study has finished and is no longer accepting participants.
In LondonPersonality disordersMedication studyAges 18–60
- Countries
- United Kingdom
- Sponsor
- King's College London (University)
CompletedNCT03408860
This study has finished and is no longer accepting participants.
In BostonPersonality disordersInterventional studyAges 18+
- Countries
- United States
- Sponsor
- Boston University Charles River Campus
TerminatedNCT03395314
Official study titleA Randomized Active Placebo Controlled Trial of Ketamine in Borderline Personality Disorder
This study ended early.
In New HavenPersonality disordersMedication studyAges 21–60
- Countries
- United States
- Sponsor
- Yale University
CompletedNCT03361826
Official study titleMagnetic Seizure Therapy for the Treatment of Treatment-Resistant Depression and Suicidal Ideation in Borderline Personality Disorder
This study has finished and is no longer accepting participants.
In TorontoPersonality disordersDevice studyAges 18–50
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health (Hospital / academic medical center)